Blueprint Medicines Corporation (BPMC) Discounted Future Market Cap - Discounting Cash Flows
Blueprint Medicines Corporation
BPMC (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value 28.55 Thou. USD
Estimated net income -51.01 Bil. USD
Estimated market capitalization 2,652 Bil. USD
Market capitalization discounted to present 1,816 Bil. USD
Shares Outstanding 63.6 Mil.
Earnings Per Share (EPS) -2.47 USD
Market Price 128.4 USD
Price to Earnings (PE) Ratio -52.42

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue 508.8 562.1 479.9 1,173 2,867 7,006 17,123
Revenue Growth Rate 104% 10.47% -5.68% 144.4% 144.4% 144.4% 144.4%
Net Income -67.09 -155.7 -1,430 -3,494 -8,540 -20,872 -51,010

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 242.7 562.1 508.8 249.4 204 180.1 793.7 66.51 44.52 21.43 27.77 11.4
Cost of Revenue 61.05 23.39 20.16 12.8 17.81 17.93 0.425 0 243.6 144.7 81.13 48.59
Gross Profit 187.2 538.7 488.7 236.6 186.2 162.1 793.3 66.51 -199.1 -123.3 -53.36 -37.19
Gross Margin -79.34% 95.84% 96.04% 94.87% 91.27% 90.04% 99.95% 100% -447.2% -575.3% -192.1% -326.2%
Operating Income -241.6 -174.3 -212 -486.3 -549.3 -648.5 302.1 -366.6 -247 -149.5 -73.61 -53.02
Operating Margin -308.4% -31.01% -41.67% -195% -269.2% -360.1% 38.07% -551.2% -554.9% -697.6% -265% -465.1%
Net Income -223.3 -155.7 -67.09 -507 -557.5 -644.1 313.9 -328.7 -236.6 -148.1 -72.5 -52.77
Net Margin -297.9% -27.7% -13.19% -203.3% -273.2% -357.7% 39.54% -494.2% -531.5% -691.3% -261% -462.9%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 242.7 562.1 508.8 249.4 204 180.1 793.7 66.51 44.52 21.43 27.77 11.4
Revenue Growth Rate 144.4% 10.47% 104% 22.22% 13.3% -77.31% 1,093% 49.39% 107.8% -22.85% 143.6%
Net Income -223.3 -155.7 -67.09 -507 -557.5 -644.1 313.9 -328.7 -236.6 -148.1 -72.5 -52.77
Net Margin -297.9% -27.7% -13.19% -203.3% -273.2% -357.7% 39.54% -494.2% -531.5% -691.3% -261% -462.9%
Net Income Growth Rate -18.78% 132.1% -86.77% -9.06% -13.44% -305.2% -195.5% 38.9% 59.76% 104.3% 37.38% 30.99%
Stockholders Equity 508.3 342.1 298.7 130.6 514.7 970.7 1,470 464.4 419 624 213.1 144
Equity Growth Rate 66.31% 14.55% 128.7% -74.62% -46.98% -33.97% 216.6% 10.82% -32.85% 192.8% 47.99% 306.4%
Return on Invested Capital (ROIC) 2,917% -21.44% -26.44% -63.85% -52.96% -73% 33.35% -71.12% -62.65% 29,760% 524.1% 2,137%
After-tax Operating Income -242.3 -176.4 -216 -487.2 -554.5 -651.5 301.1 -346.6 -257.9 -151.5 -73.04 -52.34
Income Tax Rate -0.233% -1.19% -1.86% -0.191% -0.948% -0.468% 0.336% 5.46% -4.42% -1.34% 0.775% 1.29%
Invested Capital 557 822.8 817 763 1,047 892.5 903 487.3 411.7 -0.509 -13.94 -2.45
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us